soul trial oral semaglutide cardiovascular outcomes results 2025 (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine soul trial oral semaglutide cardiovascular

Minimal Handling Requirements: The room-temperature storage and stable shelf profile reduce the logistical burden associated with refrigerated or light-sensitive peptide tools, broadening its accessibility across diverse lab environments

DF is not an essential nutrient, but it plays an important part in enhancing digestive capacity and maintaining intestinal health

Supplementation with reduced glutathione is also attracting significant interest in the field of anti-aging medicine

This means your weekly dose is now given as one injection from one pen

Mold and pollen are believed to be responsible for thunderstorm-induced asthma, coupled with moisture, a pressure drop, and charged particles in the air

Protein requirements during active weight loss and energy restriction differ from standard recommendations